Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Trilaciclib and Lurbinectidin	Cytopenia, Hemic and Lymphatic Diseases, Neoplasms by Site, Thoracic Neoplasms, agranulocytosis, bronchial neoplasm, bronchogenic carcinoma, hematologic disorder, leukocyte disorder, leukopenia, lung cancer, lung disorder, lung neoplasm, neoplasm, neutropenia, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Phase 2	2026-09-21		NCT05578326
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC	Disease Attributes, Head and Neck Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, head and neck cancer, neoplasm, refractory malignant neoplasm	Recruiting	Phase 1	2026-09-16		NCT06096038
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal cancer, esophageal disorder, head and neck squamous cell carcinoma, laryngeal disorder, laryngeal neoplasm, larynx cancer, lip cancer, lip disorder, mouth disorder, neoplasm, otorhinolaryngologic disease, respiratory system disorder, respiratory tract neoplasm, squamous cell carcinoma, squamous cell neoplasm	Active, not recruiting	Phase 2	2026-02-23		NCT03174275